Sero-prevalence and Sero-conversion Study of Health Care Workers and Their Households, Democratic Republic of the Congo

Status: Completed
Location: See location...
Intervention Type: Diagnostic Test
Study Type: Observational
SUMMARY

This is a cohort study, in which the investigators will follow-up 650 health care workers (HCW) and a selection of their households (of COVID positive and COVID negative HCW) at baseline and in three follow-up surveys, with 4 to 6 weeks of time interval. The investigators will select HCW from different wards and different health care structures in 5 communes of Kinshasa. Additionally, in the first survey among HCW, the investigators will test with different diagnostic platform to evaluate the performance of serological tests in the African setting and the effect of malaria infection on the performance of tests. An amendment is added to the protocol, stating an additional 2 surveys in april/June 2021 and October/November 2021 to evaluate impact of second wave and of vaccination campaign.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: Accepts Healthy Volunteers
View:

• For Both groups:

• Willing to provide written informed consent

• Being sick or having had COVID-19 is not an exclusion criterion

• Health care workers

• Health care worker (all categories from specialist doctors to allied and auxiliary health workers) of the selected health services

• foreseen to be employed (or place of internship) for the next three months in he selected health facility

• Household members

• Willing not to change the residence during the study period

• Household member of included Health care workers

Locations
Other Locations
Democratic Republic of the Congo
Institut Nationale de recherche Biomédicale
Kinshasa
Time Frame
Start Date: July 17, 2020
Completion Date: December 31, 2021
Participants
Target number of participants: 1200
Treatments
Health care workers
questionnaire and COVID antibody test
Household members
questionnaire and COVID antibody test
Sponsors
Collaborators: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Leads: Institute of Tropical Medicine, Belgium

This content was sourced from clinicaltrials.gov

Similar Clinical Trials